Details for 2015829910

Up to date per 05.04.2026

Actions

Title / Product Name

TUMORANTIGENSPEZIFISCHE ANTIKÖRPER UND TLR3-STIMULATION ZUR VERBESSERUNG DER LEISTUNG VON CHECKPOINT-INTERFERENZTHERAPIE VON KREBS

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2015829910

EP Publication Number

3177321

E-Number

1337524

Language

PCT Number

CA15050747

Publication Date

14.06.2017 A

25.11.2020 B1

Registration Date

25.11.2020

AT Publication Date

15.12.2020

Application Date

07.08.2015

Registration Number

Priorities

08.08.2014

201462034915 P

IPC

A61K 39/395 20060101AFI20171220BHEP

Maximum Duration of Protection

07.08.2035

Owner

Oncoquest Pharmaceuticals Inc.670-21 Sannae-ro, Sannae-myeon Miryang-SiKR

Representative

No representatives present

Inventor

MADIYALAKAN, Ragupathy9741 89th Avenue NW Edmonton, Alberta T6E 2S1CA

NICODEMUS, Christopher F.197 8th Street 706 Charlestown, Massachusetts 02129US